XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
shares in Thousands
Common Stock [Member]
Common Class A [Member]
Common Stock [Member]
Common Class B [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock, Common [Member]
Retained Earnings [Member]
Common Class A [Member]
Retained Earnings [Member]
Common Class B [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Parent [Member]
Common Class A [Member]
Parent [Member]
Common Class B [Member]
Parent [Member]
Noncontrolling Interest [Member]
Common Class A [Member]
Common Class B [Member]
Total
Balance (in shares) at Dec. 31, 2022 63,518 18,125                            
Balance at Dec. 31, 2022     $ 572,000 $ 500,642,000 $ (130,930,000)     $ 1,378,337,000 $ (4,130,000)     $ 1,744,491,000 $ 18,531,000     $ 1,763,022,000
Stock options exercised and stock awards (in shares) 228                              
Stock options exercised and stock awards     2,000 3,412,000               3,414,000       3,414,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       13,080,000               13,080,000        
Vesting of restricted share awards (in shares)   422                            
Vesting of restricted share awards     3,000 (6,964,000)               (6,961,000)       (6,961,000)
Issuance of common stock under employee stock purchase plan (in shares) 102                              
Issuance of common stock under employee stock purchase plan       2,828,000               2,828,000       2,828,000
Common stock repurchases (in shares) (623) (84)                            
Common stock repurchases         (25,280,000)             (25,280,000)       (25,280,000)
Cash dividends declared           $ (8,897,000) $ (2,692,000)     $ (8,897,000) $ (2,692,000)          
Foreign currency translation adjustment                 232,000     232,000        
Net income               90,455,000       90,455,000 335,000      
Balance (in shares) at Mar. 31, 2023 63,225 18,463                            
Balance at Mar. 31, 2023     577,000 512,998,000 (156,210,000)     1,457,203,000 (3,898,000)     1,810,670,000 18,866,000     1,829,536,000
Balance (in shares) at Dec. 31, 2022 63,518 18,125                            
Balance at Dec. 31, 2022     572,000 500,642,000 (130,930,000)     1,378,337,000 (4,130,000)     1,744,491,000 18,531,000     1,763,022,000
Foreign currency translation adjustment                               (187,000)
Net income                               269,948,000
Balance (in shares) at Sep. 30, 2023 62,053 17,989                            
Balance at Sep. 30, 2023     804,000 533,648,000 (16,169,000)     1,385,646,000 (4,317,000)     1,899,612,000 19,471,000     1,919,083,000
Balance (in shares) at Mar. 31, 2023 63,225 18,463                            
Balance at Mar. 31, 2023     577,000 512,998,000 (156,210,000)     1,457,203,000 (3,898,000)     1,810,670,000 18,866,000     1,829,536,000
Stock options exercised and stock awards (in shares) 237                              
Stock options exercised and stock awards     1,000 3,479,000               3,480,000       3,480,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       5,952,000               5,952,000       5,952,000
Vesting of restricted share awards       (54,000)               (54,000)       (54,000)
Common stock repurchases (in shares) (890) (195)                            
Common stock repurchases         (40,305,000)             (40,305,000)       (40,305,000)
Cash dividends declared           (8,812,000) (2,725,000)     (8,812,000) (2,725,000)     $ (8,812,000) $ (2,725,000)  
Foreign currency translation adjustment                 1,689,000     1,689,000       1,689,000
Net income               98,275,000       98,275,000 249,000     98,524,000
Balance (in shares) at Jun. 30, 2023 62,572 18,268                            
Balance at Jun. 30, 2023     578,000 522,375,000 (196,515,000)     1,543,941,000 (2,209,000)     1,868,170,000 19,115,000     1,887,285,000
Stock options exercised and stock awards (in shares) 124                              
Stock options exercised and stock awards     1,000 1,888,000               1,889,000       1,889,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       6,265,000               6,265,000       6,265,000
Issuance of common stock under employee stock purchase plan (in shares) 107                              
Issuance of common stock under employee stock purchase plan     1,000 3,123,000               3,124,000       3,124,000
Common stock repurchases (in shares) (750) (279)                            
Common stock repurchases         (44,174,000)             (44,174,000)       (44,174,000)
Cash dividends declared           (10,574,000) (3,255,000)     (10,574,000) (3,255,000)     (10,574,000) (3,255,000)  
Foreign currency translation adjustment                 (2,108,000)     (2,108,000)       (2,108,000)
Net income               80,278,000       80,278,000 356,000     80,634,000
Balance (in shares) at Sep. 30, 2023 62,053 17,989                            
Balance at Sep. 30, 2023     804,000 533,648,000 (16,169,000)     1,385,646,000 (4,317,000)     1,899,612,000 19,471,000     1,919,083,000
Retirement of treasury shares and par value adjustment     224,000 (3,000) 224,520,000     (224,744,000)       (3,000)       (3,000)
Balance (in shares) at Dec. 31, 2023 61,461 16,364                            
Balance at Dec. 31, 2023     806,000 542,046,000 (119,835,000)     1,450,025,000 (2,163,000)     1,870,879,000       1,890,416,000
Stock options exercised and stock awards (in shares) 383                              
Stock options exercised and stock awards     4,000 5,997,000               6,001,000       6,001,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan                       14,090,000        
Vesting of restricted share awards (in shares)   351                            
Vesting of restricted share awards     4,000 (9,486,000)               (9,482,000)       (9,482,000)
Issuance of common stock under employee stock purchase plan (in shares) 97                              
Issuance of common stock under employee stock purchase plan     1,000 3,354,000               3,355,000       3,355
Common stock repurchases (in shares) (128)                              
Common stock repurchases         (5,627,000)             (5,627,000)       (5,627,000)
Cash dividends declared           (10,467,000) (2,964,000)     (10,467,000) (2,964,000)          
Foreign currency translation adjustment                 (1,891,000)     (1,891,000)        
Net income               71,608,000       71,608,000 (119,000)     71,489,000
Balance (in shares) at Mar. 31, 2024 61,813 16,715                            
Balance at Mar. 31, 2024     815,000 556,001,000 (125,462,000)     1,508,202,000 (4,054,000)     1,935,502,000 19,418,000     1,954,920,000
Balance (in shares) at Dec. 31, 2023 61,461 16,364                            
Balance at Dec. 31, 2023     806,000 542,046,000 (119,835,000)     1,450,025,000 (2,163,000)     1,870,879,000       1,890,416,000
Foreign currency translation adjustment                               (1,806,000)
Net income                               229,692,000
Balance (in shares) at Sep. 30, 2024 62,308 16,695                            
Balance at Sep. 30, 2024     820,000 577,665,000 (129,644,000)     1,638,257,000 (3,969,000)     2,083,129,000 19,828,000     2,102,957,000
Balance (in shares) at Mar. 31, 2024 61,813 16,715                            
Balance at Mar. 31, 2024     815,000 556,001,000 (125,462,000)     1,508,202,000 (4,054,000)     1,935,502,000 19,418,000     1,954,920,000
Stock options exercised and stock awards (in shares) 134                              
Stock options exercised and stock awards     1,000 2,098,000               2,099,000       2,099,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       5,515,000               5,515,000       5,515,000
Vesting of restricted share awards       (10,000)               (10,000)       (10,000)
Common stock repurchases (in shares) (78) (15)                            
Common stock repurchases         (3,953,000)             (3,953,000)       (3,953,000)
Cash dividends declared           (10,523,000) (3,024,000)     (10,523,000) (3,024,000)     (10,523,000) (3,024,000)  
Foreign currency translation adjustment                 (873,000)     (873,000)       (873,000)
Net income               78,661,000       78,661,000 122,000     78,783,000
Balance (in shares) at Jun. 30, 2024 61,869 16,700                            
Balance at Jun. 30, 2024     816,000 563,604,000 (129,415,000)     1,573,316,000 (4,927,000)     2,003,394,000 19,540,000     2,022,934,000
Stock options exercised and stock awards (in shares) 341                              
Stock options exercised and stock awards     3,000 5,257,000               5,260,000       5,260,000
Stock-based compensation related to stock options, restricted shares and employee stock purchase plan       5,293,000               5,293,000       5,293,000
Issuance of common stock under employee stock purchase plan (in shares) 99                              
Issuance of common stock under employee stock purchase plan     1,000 3,511,000               3,512,000       3,512,000
Common stock repurchases (in shares) (1) (5)                            
Common stock repurchases         (229,000)             (229,000)       (229,000)
Cash dividends declared           $ (11,185,000) $ (3,006,000)     $ (11,185,000) $ (3,006,000)     $ (11,185,000) $ (3,006,000)  
Foreign currency translation adjustment                 958,000     958,000       958,000
Net income               79,132,000       79,132,000 288,000     79,420,000
Balance (in shares) at Sep. 30, 2024 62,308 16,695                            
Balance at Sep. 30, 2024     $ 820,000 $ 577,665,000 $ (129,644,000)     $ 1,638,257,000 $ (3,969,000)     $ 2,083,129,000 $ 19,828,000     $ 2,102,957,000